Table 1.

Cumulative quantitation of donor cell distribution using RQ-STR analysis in double cord transplantation of total MNCs


HLA disparity

No. experiments (no. mice)

Donor A, % STR*

Donor B, % STR*

Donor cell ratio

No. mice with predominance
Full match   3 (5)   82.8 ± 7.1   17.2 ± 7.1   4.8:1   4 of 5  
1 mismatch   2 (8)   83.8 ± 2.2   16.2 ± 2.2   5.2:1   8 of 8  
2 mismatches   2 (5)   74.3 ± 5.6   25.7 ± 5.6   2.9:1   3 of 5  
Full mismatch   2 (4)   80.6 ± 3.5   19.4 ± 3.5   4.2:1   3 of 4  
Total
 
9 (22)
 
80.7 ± 2.2
 
19.3 ± 2.2
 
4.2:1
 
18 of 22
 

HLA disparity

No. experiments (no. mice)

Donor A, % STR*

Donor B, % STR*

Donor cell ratio

No. mice with predominance
Full match   3 (5)   82.8 ± 7.1   17.2 ± 7.1   4.8:1   4 of 5  
1 mismatch   2 (8)   83.8 ± 2.2   16.2 ± 2.2   5.2:1   8 of 8  
2 mismatches   2 (5)   74.3 ± 5.6   25.7 ± 5.6   2.9:1   3 of 5  
Full mismatch   2 (4)   80.6 ± 3.5   19.4 ± 3.5   4.2:1   3 of 4  
Total
 
9 (22)
 
80.7 ± 2.2
 
19.3 ± 2.2
 
4.2:1
 
18 of 22
 

Total MNCs equivalent to 5 × 104 CD34+ cells from each UCB unit were mixed and transplanted. Percentages of donor A (dominant party) and donor B (nondominant party) were determined by measuring the area of donor-specific STR peaks among all human-specific STR peaks, and the donor A-to-donor B cell ratio was calculated. Ratios greater than 3:1 were considered dominant, and the mice were scored as donor predominant. HLA disparity refers to HLA-A, HLA-B, and HLA-DR.

*

Values presented as mean ± SEM.

Close Modal

or Create an Account

Close Modal
Close Modal